DAFTAR PUSTAKA

Akaputra, R., Burhan, E., & Nawas, A. (2011). Karakteristik dan Evaluasi
Perjalanan Penyakit Multidrug Resistant Tuberculosis dengan Diabetes
Melitus dan Non Diabetes Melitus, 33(2), 92–102.
Anderson, L. F., Tamne, S., Watson, J. P., Cohen, T., Mitnick, C., Brown, T., …
Abubakar, I. (2013). Treatment Outcome of Multi-drug Resistant
Tuberculosis in The United Kingdom: Retrospective-Prospective Cohort
Study From 2004 to 2007. Euro Surveillance : Bulletin Européen Sur Les
Maladies Transmissibles = European Communicable Disease Bulletin,
18(40), 1–10. http://doi.org/10.2807/1560-7917.ES2013.18.40.20601
Balabanova, Y., Nikolayevskyy, V., Ignatyeva, O., Kontsevaya, I., Clare, M.,
Shakhmistova, A., … Mironova, S. (2011). Survival of Civilian and Prisoner
Drug-Sensitive , Multi- and Extensive Drug- Resistant Tuberculosis Cohorts
Prospectively Followed in Russia, 6(6).
http://doi.org/10.1371/journal.pone.0020531
Balabanova, Y., Radiulyte, B., Davidaviciene, E., Hooper, R., Ignatyeva, O.,
Nikolayevskyy, V., & Drobniewski, F. a. (2011). Survival of Drug Resistant
Tuberculosis Patients in Lithuania: Retrospective National Cohort Study.
BMJ Open, 1(2), e000351–e000351. http://doi.org/10.1136/bmjopen-2011-
000351
Balai Besar Pelatihan Kesehatan. (2016). Manajemen Terpadu Pengendalian
Tuberkulosis Resisten Obat (MTPTRO). Jakarta.
Bonita, R; Beaglehole, R; Kjellstrom, T. (2006). Basic Epidemiology (2nd ed.).
Geneva: World Health Organization.
Cahyadi, A. (2011). Tuberkulosis Paru pada Pasien Diabetes Mellitus. Journal
Indonesia Medical Association, 61(April 2011), 173–178.
Charles, M., Vilbrun, S. C., Koenig, S. P., Hashiguchi, L. M., Mabou, M. M.,
Ocheretina, O., & Pape, J. W. (2014). Treatment Outcomes for Patients with
Multidrug-Resistant Tuberculosis in Post-Earthquake Port-au-Prince, Haiti.
American Journal of Tropical Medicine and Hygiene, 91(4), 715–721.
http://doi.org/10.4269/ajtmh.14-0161
Curry International Tuberculosis Center. (2011). Drug-Resistant Tuberculosis a
Survival Guide for Clinicians. In Clinics in chest medicine (2nd ed.).
California Department of Public Health. Retrieved from
www.currytbcenter.ucsf.edu/drtb
Dahlan, M. S. (2009). Analisis Survival: Dasar-Dasar Teori dan Aplikasi
Program Stata. Jakarta: CV Sagung Seto.
Departemen Kesehatan RI. (2008). Petunjuk Teknis Pengukuran Faktor Risiko
Diabetes Melitus. Jakarta: Direktorat Pengendalian Penyakit Tidak Menular
Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan.
80
 81

Erawatyningsih, E., Purwanta, & Subekti, H. (2009). Faktor-faktor yang

mempengaruhi ketidakpatuhan berobat pada penderita tuberkulosis paru.
Berita Kedokteran Masyarakat, 25(3), 117–124.
Fatmah. (2006). Respons Imunitas yang Rendah pada Tubuh Manusia Usia
Lanjut. Makara Kesehatan, 10(1), 47–53.
Gadallah, M. A., Mokhtar, A., Rady, M., El-Moghazy, E., Fawzy, M., & Kandil,
S. K. (2015). Prognostic Factors of Treatment among Patients with
Multidrug-Resistant Tuberculosis in Egypt. Journal of the Formosan
Medical Association, 1–7. http://doi.org/10.1016/j.jfma.2015.10.002
Getachew, T., Bayray, A., & Weldearegay, B. (2013). Survival and Predictors of
Mortality Among Patients Under Multi-drug Resistant Tuberculosis
Treatment in Ethiopia: St. Peter’s Specialized Tuberculosis Hospital,
Ethiopia. International Journal of Pharmaceutical Sciences and Research,
4(2), 776–787.
Jain, K., Desai, M., Solanki, R., & Dikshit, R. K. (2014). Treatment outcome of
standardized regimen in patients with multidrug resistant tuberculosis, 5(2),
145–149. http://doi.org/10.4103/0976-500X.130062
Kemenkes RI. (2015). Tuberkulosis Temukan Obati Sampai Sembuh. Infodatin.
Retrieved from
http://www.depkes.go.id/download.php?file=download/pusdatin/infodatin/inf
odatin_tb.pdf
Kementerian Kesehatan RI. (2010). Rencana Operasional Promosi Kesehatan
dalam Pengendalian HIV dan AIDS. Jakarta: Pusat Promosi Kesehatan
Kementerian Kesehatan Republik Indonesia.
Kementerian Kesehatan RI. (2013). Petunjuk Teknik Manajemen Terpadu
Pengendalian Tuberkulosis Resistan Obat. Jakarta: Direktorat Jenderal
Pengendalian Penyakit dan Penyehatan Lingkungan.
http://doi.org/10.1017/CBO9781107415324.004
Kementerian Kesehatan RI. (2014a). Pedoman Nasional Pengendalian
Tuberkulosis. Jakarta: Direktorat Jenderal Pengendalian Penyakit dan
Penyehatan Lingkungan.
Kementerian Kesehatan RI. (2014b). Rencana Aksi Nasional Programmatic
Management of Drug resistance Tuberculosis Pengendalian Tuberkulosis
Indonesia : 2011-2014.
Kempker, R. R., Kipiani, M., Mirtskhulava, V., Tukvadze, N., Magee, M. J., &
Blumberg, H. M. (2016). Acquired Drug Resistance in Mycobacterium
tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant
Tuberculosis, 21(6).
Khan, M. A., Mehreen, S., Basit, A., Khan, R. A., & Javaid, A. (2015). Predictors
of Poor Outcomes among Patients Treated for Multidrug-Resistant
Tuberculosis at Tertiary Care Hospital in Pakistan, 7(3), 162–172.
81
 82

http://doi.org/10.5829/idosi.aejts.2015.7.3.9499
Kim, D. H., Kim, H. J., Park, S.-K., Kong, S.-J., Kim, Y. S., Kim, T.-H., … Shim,
T. S. (2008). Treatment outcomes and long-term survival in patients with
extensively drug-resistant tuberculosis. American Journal of Respiratory and
Critical Care Medicine, 178(10), 1075–1082.
http://doi.org/10.1164/rccm.200801-132OC
Kleinbaum, David, G; Klein, M. (2012). Survival Analysis A Self-Learning Text.
(W. Gail, M; Krickeberg, K; Samet, J, M; Tsiatis, A; Wong, Ed.)Journal of
Chemical Information and Modeling (Third, Vol. 53). New York: (Springer
Science and Business Media.
http://doi.org/10.1017/CBO9781107415324.004
Kothari, C. R. (2004). Research Methodology Methods and Techniques (Second
Rev). New Delhi: New Age International (P) Ltd, Publishers.
http://doi.org/10.1017/CBO9781107415324.004
Kurbatova, E. V, Taylor, A., Gammino, V. M., Bayona, J., Becerra, M.,
Danilovitz, M., … Cegielski, J. P. (2012). Predictors of poor outcomes
among patients treated for multidrug-resistant tuberculosis at DOTS-plus
projects. Tuberculosis, 92(5), 397–403.
http://doi.org/10.1016/j.tube.2012.06.003
Leimane, V., Riekstina, V., Holtz, T. H., Zarovska, E., Skripconoka, V., Thorpe,
L. E., … Wells, C. D. (2005). Clinical Outcome of Individualised Treatment
of Multidrug Resistant Tuberculosis in Latvia : A Retrospective Cohort
Study. Lancet, 365.
Liu, C. H., Li, L., Chen, Z., Wang, Q., Hu, Y. L., Zhu, B., & Woo, P. C. Y.
(2011). Characteristics and treatment outcomes of patients with MDR and
XDR tuberculosis in a TB referral hospital in beijing: A 13-year experience.
PLoS ONE, 6(4). http://doi.org/10.1371/journal.pone.0019399
Lockman, S., Kruuner, A., Binkin, N., Levina, K., Wang, Y., Danilovitsh, M., …
Tappero, J. (2001). Clinical Outcomes of Estonian Patients with Primary
Multidrug-Resistant versus Drug-Susceptible Tuberculosis. Clinical
Infectious Diseases, 32(3), 373–380. http://doi.org/10.1086/318489
Milanov, V., Falzon, D., Zamfirova, M., Varleva, T., Bachiyska, E., Koleva, A.,
& Dara, M. (2015). Factors associated with treatment success and death in
cases with multidrug-resistant tuberculosis in Bulgaria, 2009-2010.
International Journal of Mycobacteriology, 4(2), 131–137.
http://doi.org/10.1016/j.ijmyco.2015.03.005
Nawas, A. (2010). Penatalaksanaan TB MDR dan Strategi DOTS Plus. Jurnal
Tuberkulosis Indonesia, 7, 1–7.
Patel, S. V, Nimavat, K. B., Alpesh, P. B., Shukla, L. K., Shringarpure, K. S.,
Kedar, G., & Joshi, C. C. (2015). Treatment outcome among cases of
multidrug-resistant tuberculosis ( MDR TB ) in Western India : A
82

prospective study. Journal of Infection and Public Health.

 83

http://doi.org/10.1016/j.jiph.2015.11.011
Porta, M. (2008). A Dictionary of Epidemiology. (I. E. Association, Ed.) (Fifth).
New York: Oxford University Press.
http://doi.org/10.1017/CBO9781107415324.004
Silman, Alan J; Macfarlane, G. J. (2002). Epidemiological Studies A Practical
Guide (Second). United Kingdom: Cambridge University Press.
Siswanto; Reviono; Aphridasari, Jatu; Susanto, Y. S. (2016). Faktor Prediktor
Hasil Akhir Pengobatan Pasien Tuberkulosis Resisten Obat di RSUD Dr
Moewardi Surakarta, 1–13.
Sjahrurachman, A. (2010). Diagnosis dan Faktor yang Mempengaruhi Terjadinya
TB-MDR. Jurnal Tuberkulosis Indonesia, 7, 8–10.
Soepandi, P, Z. (2010). Diagnosis dan Penatalaksanaan Tb - MDR. Cermin Dunia
Kesehatan, 37(7), 497–501.
Sun, Y., Harley, D., Vally, H., & Sleigh, A. (2015). Comparison of Characteristics
and Mortality in Multidrug Resistant (MDR) and Non-MDR Tuberculosis
Patients in China. BMC Public Health, 15(1), 1027.
http://doi.org/10.1186/s12889-015-2327-8
Tang, S., Tan, S., Yao, L., Li, F., Li, L., Guo, X., … Hao, X. (2013). Risk Factors
for Poor Treatment Outcomes in Patients with MDR-TB and XDR-TB in
China : Retrospective Multi- Center Investigation, 8(12), 1–8.
http://doi.org/10.1371/journal.pone.0082943
Webb, P and Bain, C. (2011). Essential Epidemiology An Introduction for
Students and Health Professionals (2nd ed.). New York: Cambridge
University Press. http://doi.org/10.1017/CBO9781107415324.004
WHO. (2014a). Companion Handbook to The WHO Guidelines for The
Programmatic Management of Drug-resistant Tuberculosis. Geneva.
WHO. (2014b). Companion Handbook To The WHO Guidelines For The
Programmatic Management Of Drug-Resistant Tuberculosis. Geneva.
WHO. (2015a). Global Tuberculosis Report 2015. The effects of brief mindfulness
intervention on acute pain experience: An examination of individual
difference (20th ed., Vol. 1). http://doi.org/10.1017/CBO9781107415324.004
WHO. (2015b). Multidrug Resistant Tuberculosis (MDR-TB) 2015 Update.
83